UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,507,278 shares of the medical equipment provider’s stock after selling 53,042 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Intuitive Surgical were worth $1,231,750,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Hazlett Burt & Watson Inc. boosted its holdings in Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. boosted its stake in shares of Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after acquiring an additional 20 shares during the period. Ullmann Wealth Partners Group LLC grew its position in shares of Intuitive Surgical by 1.6% during the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after purchasing an additional 21 shares in the last quarter. Meeder Advisory Services Inc. grew its position in shares of Intuitive Surgical by 0.3% during the third quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock worth $3,629,000 after purchasing an additional 22 shares in the last quarter. Finally, One Wealth Management Investment & Advisory Services LLC raised its stake in Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after purchasing an additional 23 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent analyst reports. Raymond James upped their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Leerink Partners boosted their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Finally, Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price objective for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $526.06.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,459 shares of company stock valued at $26,080,251 in the last ninety days. 0.80% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $538.55 on Thursday. The firm has a market capitalization of $191.82 billion, a PE ratio of 86.58, a PEG ratio of 5.28 and a beta of 1.39. The stock’s fifty day moving average is $507.94 and its 200 day moving average is $466.79. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.